Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Eletrobras ADR

Start price
Target price
Perf. (%)
€6.45
25.03.22
-
25.03.23
-16.28%
27.03.23

buy
Vermilion Energy Inc.

Start price
Target price
Perf. (%)
€20.40
25.03.22
-
25.03.23
-44.12%
27.03.23

buy
Suncor Energy

Start price
Target price
Perf. (%)
€29.92
25.03.22
-
25.03.23
-7.27%
27.03.23

Kineta Inc.

Start price
Target price
Perf. (%)
€12.46
24.03.22
-
24.03.23
-23.03%
02.04.22

Probably not worthwhile Investment
buy
Adomos

Start price
Target price
Perf. (%)
€0.029
24.03.22
€0.030
24.03.23
-96.58%
04.03.23

Could be worthwhile Investment >10% per year
buy
Weng Fine Art AG NA

Start price
Target price
Perf. (%)
€23.80
24.03.22
€40.00
25.03.25
-81.81%
19.07.24

Could be worthwhile Investment >10% per year
Capable Management
Strong uniques
Top 10 in its market
buy
RA Medical Systems Inc.

Start price
Target price
Perf. (%)
€23.38
23.03.22
€5.00
23.03.23
-87.98%
18.10.22

Could be worthwhile Investment >10% per year
buy
HelloFresh SE

Start price
Target price
Perf. (%)
€41.69
23.03.22
-
23.03.23
-36.87%
16.11.22

buy
Cell Impact AB

Start price
Target price
Perf. (%)
€2.06
21.03.22
-
20.06.25
-99.22%
11.03.24

Could be worthwhile Investment >10% per year
buy
PAVmed Inc

Start price
Target price
Perf. (%)
€1.35
21.03.22
€8.00
21.03.23
-14.92%
02.04.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Revenue decline/stagnation expected
Lipocine Inc.

Start price
Target price
Perf. (%)
€25.25
21.03.22
€0.000
21.03.23
-19.90%
02.04.22

Below average Management
high free float
High risks for its business
Unknown brand
PAVmed Inc

Start price
Target price
Perf. (%)
€1.41
20.03.22
-
20.03.23
-80.13%
21.03.23

Probably not worthwhile Investment
buy
American Lithium Corp

Start price
Target price
Perf. (%)
€2.22
16.03.22
€2.00
16.03.23
-36.35%
26.11.22

EBIT growth >5% per year expected
Fair valuation
Very low/no dividend yield expected
negative Cash Flow expected
buy
Agrogeneration

Start price
Target price
Perf. (%)
€0.13
16.03.22
€0.20
16.03.23
-39.21%
15.11.22

Could be worthwhile Investment >10% per year
buy
Sphere 3D Corp.

Start price
Target price
Perf. (%)
€10.85
15.03.22
-
15.03.23
-82.01%
16.03.23

Could be worthwhile Investment >10% per year
buy
Eurobio scientific

Start price
Target price
Perf. (%)
€19.28
14.03.22
€21.00
14.03.23
-10.58%
05.10.22

Could be worthwhile Investment >10% per year
buy
Ocean Power Technologies Inc.

Start price
Target price
Perf. (%)
€1.50
11.03.22
€2.00
11.03.23
-23.76%
09.04.22

Very Future proof/growth oriented business model
Risky Investment
Camber Energy Inc.

Start price
Target price
Perf. (%)
€49.75
11.03.22
-
11.03.23
-28.64%
14.03.22

Probably not worthwhile Investment
buy
Nestle Nam. ADR

Start price
Target price
Perf. (%)
€111.50
10.03.22
€145.00
08.02.27
-5.40%
19.07.24

Could be worthwhile Investment >10% per year
Market Leader or Top 3
Very small cyclical dependencies
Well known brand
buy
Arianne Phosphate Inc.

Start price
Target price
Perf. (%)
€0.44
09.03.22
€0.80
09.04.22
13.64%
10.04.22

Could be worthwhile Investment >10% per year
buy
Aya Gold & Silver Inc.

Start price
Target price
Perf. (%)
€7.55
09.03.22
-
09.03.23
-33.64%
10.03.23

Stable Large shareholder and/or long term investor
Revenue growth >5% per year expected
Higher risks for its business
Little known brand
buy
Deutsche Konsum REIT AG

Start price
Target price
Perf. (%)
€13.45
09.03.22
-
09.03.23
-40.07%
09.03.23

buy
Camber Energy Inc.

Start price
Target price
Perf. (%)
€54.00
09.03.22
-
09.03.23
-29.17%
18.03.22

Risky Investment
buy
Anglo Asian Mining

Start price
Target price
Perf. (%)
€1.24
08.03.22
-
08.03.23
-7.26%
19.03.22

Probably not worthwhile Investment
Camber Energy Inc.

Start price
Target price
Perf. (%)
€69.50
08.03.22
-
08.03.23
-25.90%
09.03.22

Revenue growth >5% per year expected